Hypoglycaemia is uncommon with a combination of antidiabetic drugs and bedtime NPH insulin for type 2 diabetes

Practical Diabetes International

Volumn 21, Issue 5, 2004, Pages 179-182

  Allen, Kate V ^a   McAulay, Vincent ^a   Sommerfield, Andrew J ^a   Frier, Brian M ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Hypogylcaemia; Impaired awareness of hypolycaemia; Insulin antidiabetic drugs; Type 2 diabetes

Indexed keywords

GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; ISOPHANE INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; AGED; ARTICLE; AWARENESS; CHRONOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MALE; MAXIMUM TOLERATED DOSE; NIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SELF MEDICATION; SINGLE DRUG DOSE; VALIDATION PROCESS;

EID: 3242755096     PISSN: 13578170     EISSN: None     Source Type: Journal    
DOI: 10.1002/pdi.637     Document Type: Article

References (22)

1. Cusi K, Cunningham GR, Comstock JP. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM. Diabetes Care 1995; 18: 843-851.
2. Reaven GM, Hollenbeck C, Jeng C-Y, et al. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24h in patients with NIDDM. Diabetes 1988; 37: 1020-1024.
3. Riddle MC. Evening insulin strategy. Diabetes Care 1990; 13: 676-686.
4. Pramming S, Thorsteinsson B, Bendtson I, et al. Symptomatic hypoglycaemia in 411 Type 1 diabetic patients. Diabetic Med 1991; 8: 217-222.
5. Soneru IL, Agrawal L, Murphy JC, et al. Comparison of morning or bedtime insulin with and without glyburide in secondary sulfonylurea failure. Diabetes Care 1993; 16: 896-901.
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
7. Yki-Jarvinen H, Ryysy L, Nikkila K, et al. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. Ann Intern Med 1999; 130: 389-396.
8. Furlong NJ, Hulme SA, O'Brien SV, et al. Repaglinide versus metformin in combination with bedtime NPH insulin in patients with type 2 diabetes established on insulin/metformin combination therapy. Diabetes Care 2002; 25: 1685-1690.
9. Deary IJ, Hepburn DA, MacLeod KM, et al. Partitioning the symptoms of hypoglycaemia using multisample confirmatory factor analysis. Diabetologia 1993; 36: 771-777.
10. Jaap AJ, Jones GC, McCrimmon RJ, et al. Perceived symptoms of hypoglycaemia in elderly type 2 diabetic patients treated with insulin. Diabetic Med 1998; 15: 398-401.
11. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type 1 diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994; 17: 697-703.
12. Henderson JN, Allen KV, Deary IJ, et al. Hypoglycaemia in insulin-treated type 2 diabetes mellitus: frequency, symptoms and impaired awareness. Diabetic Med 2003; 20: 1016-1021.
13. Hepburn DA, MacLeod KM, Pell ACH, et al. Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabetic Med 1993; 10: 231-237.
14. Frier BM. Hypoglycaemic valleys: an under-recognised problem in type 2 diabetes? Int J Clin Pract 2002; Suppl 129: 12-19.
15. Muhlhauser I, Overmann H, Bender R, et al. Risk factors of severe hypoglycaemia in adult patients with type 1 diabetes - a prospective population based study. Diabetologia 1998; 41: 1274-1282.
16. The EURODIAB IDDM Complications Study Group. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994; 37: 278-285.
17. Pramming S, Pedersen-Bjergaard U, Heller S, et al. Severe hypoglycaemia in unselected patients with type 1 diabetes: A cross-sectional multicentre survey. Diabetologia 2000; 43(Suppl 1): A194 (abstract).
18. Ter Braak EWMT, Appelman AMMF, Van de Laak MF, et al. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care 2000; 23: 1467-1471.
19. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997; 46: 271-286.
20. MacLeod KM, Hepburn DA, Frier BM. Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabetic Med 1993; 10: 238-245.
21. Chico A, Vidal-Rios P, Subira M, et al. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003; 26: 1153-1157.
22. McAulay V, Deary IJ, Frier BM. Symptoms of hypoglycaemia in people with diabetes. Diabetic Med 2001; 18: 690-705.